Hansen Kristina K, Saifeddine Mahmoud, Hollenberg Morley D
Department of Pharmacology and Therapeutics, University of Calgary Faculty of Medicine, Calgary, Alberta, Canada.
Immunology. 2004 Jun;112(2):183-90. doi: 10.1111/j.1365-2567.2004.01870.x.
Proteinase-activated receptors (PARs) can activate a number of signalling events, including T-cell signal-transduction pathways. Recent data suggest that the activation of PARs 1, 2 and 3 in Jurkat T-leukaemic cells induces tyrosine phosphorylation of the haematopoietic signal transducer protein, VAV1. To activate the PARs, this study used the agonist peptides SFLLRNPNDK, SLIGKVDGTS and TFRGAPPNSF, which are based on the sequences of the tethered ligand sequences of human PARs 1, 2 and 3, respectively. Here, we show that peptides based on either the human or murine PAR(3)-derived tethered ligand sequences (TFRGAP-NH(2) or SFNGGP-NH(2)) do not activate PAR(3), but rather activate PARs 1 and 2, either in Jurkat or in other PAR-expressing cells. Furthermore, whilst thrombin activates only Jurkat PAR(1), trypsin activates both PARs 1 and 2 and also disarms Jurkat PAR(1) for thrombin activation. We conclude therefore that in Jurkat or related T cells, signalling via PARs that can affect VAV1 phosphorylation is mediated via PAR 1 or 2, or both, and that distinct serine proteinases may potentially differentially affect T-cell function in the settings of inflammation.
蛋白酶激活受体(PARs)可激活多种信号转导事件,包括T细胞信号转导途径。最近的数据表明,Jurkat T白血病细胞中PARs 1、2和3的激活会诱导造血信号转导蛋白VAV1的酪氨酸磷酸化。为了激活PARs,本研究使用了激动剂肽SFLLRNPNDK、SLIGKVDGTS和TFRGAPPNSF,它们分别基于人PARs 1、2和3的拴系配体序列。在此,我们表明,基于人或小鼠PAR(3)衍生的拴系配体序列(TFRGAP-NH(2)或SFNGGP-NH(2))的肽不会激活PAR(3),而是在Jurkat细胞或其他表达PAR的细胞中激活PARs 1和2。此外,虽然凝血酶仅激活Jurkat PAR(1),但胰蛋白酶可激活PARs 1和2,并且还会使Jurkat PAR(1)对凝血酶激活失去反应。因此,我们得出结论,在Jurkat或相关T细胞中,通过可影响VAV1磷酸化的PARs进行的信号转导是通过PAR 1或2或两者介导的,并且在炎症环境中,不同的丝氨酸蛋白酶可能会对T细胞功能产生不同的影响。